Reaproveitamento de medicamentos para COVID-19: uma visão geral
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Saúde (Santa Maria) |
Texto Completo: | https://periodicos.ufsm.br/revistasaude/article/view/67893 |
Resumo: | The SARS-CoV-2 virus can cause infections in both animals and humans. COVID-19 is an infectious disease caused by this virus and known today for generating great concern worldwide, as it has high rates of transmissibility and pathogenicity and high death rates known worldwide as a result of this infection. For this reason, potential therapeutic strategies are analyzed to contribute to the fight against the COVID-19 pandemic. Some of these therapeutic strategies are carried out through the repositioning of medications. For this opinion study, scientific articles were used, which discussed the repositioning of drugs in COVID-19 and the use of vitamins and minerals in the treatment. It can be seen that the reuse of drugs has several advantages over the implementation of a new drug, such as reduced time to start treatment and reduced financial investment, which leads to a delay in the arrival of purchased drugs and products, especially during this period. pandemic. This drug replacement, with its immediate administration to the patient, ends up causing a delay in the development of the disease course, as well as a lower risk of treatment failure. So far, there is no regularized, standardized and widely publicized therapeutic resource available to the population, however, further studies on this topic should necessarily be encouraged. |
id |
UFSM-14_7870aba9801f043a40638664dd6822cf |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/67893 |
network_acronym_str |
UFSM-14 |
network_name_str |
Saúde (Santa Maria) |
repository_id_str |
|
spelling |
Reaproveitamento de medicamentos para COVID-19: uma visão geralReposicionamento de medicamentos. Redirecionamento de medicamentos. SARS-CoV-2. Coronavírus.The SARS-CoV-2 virus can cause infections in both animals and humans. COVID-19 is an infectious disease caused by this virus and known today for generating great concern worldwide, as it has high rates of transmissibility and pathogenicity and high death rates known worldwide as a result of this infection. For this reason, potential therapeutic strategies are analyzed to contribute to the fight against the COVID-19 pandemic. Some of these therapeutic strategies are carried out through the repositioning of medications. For this opinion study, scientific articles were used, which discussed the repositioning of drugs in COVID-19 and the use of vitamins and minerals in the treatment. It can be seen that the reuse of drugs has several advantages over the implementation of a new drug, such as reduced time to start treatment and reduced financial investment, which leads to a delay in the arrival of purchased drugs and products, especially during this period. pandemic. This drug replacement, with its immediate administration to the patient, ends up causing a delay in the development of the disease course, as well as a lower risk of treatment failure. So far, there is no regularized, standardized and widely publicized therapeutic resource available to the population, however, further studies on this topic should necessarily be encouraged.O vírus SARS-CoV-2 pode ocasionar infecções tanto em animais como em humanos. A COVID-19 é uma doença infecciosa causada por esse vírus e conhecida na atualidade por gerar grande preocupação à nível mundial, visto que possui altas taxas de transmissibilidade e patogenicidade e elevados índices de morte mundialmente conhecidos, em decorrência desta infecção. Por este motivo, estratégias terapêuticas potenciais são analisadas para contribuir no combate à pandemia de COVID-19. Algumas dessas estratégias terapêuticas são realizadas por meio do reposicionamento de medicamentos. Para este estudo de opinião foram utilizados artigos científicos, que trouxeram como assunto abordado o reposicionamento de fármacos na COVID-19 e a utilização de vitaminas e minerais no tratamento. Pode-se observar que o reaproveitamento de fármacos possui diversas vantagens sobre a implementação de um novo medicamento, como redução de tempo para o início do tratamento e de investimento financeiro, que gera a demora na chegada dos medicamentos e produtos comprados, em especial nesse período pandêmico. Essa reposição de fármacos, com sua administração imediata no paciente, acaba gerando o retardo no desenvolvimento do curso da doença, assim como o menor risco de falha no tratamento. Até o momento, não há recurso terapêutico regularizado, padronizado e amplamente divulgado à população, no entanto, mais estudos sobre esse tema devem ser necessariamente incentivados.Universidade Federal de Santa Maria2022-05-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.ufsm.br/revistasaude/article/view/6789310.5902/2236583467893Saúde (Santa Maria); Revista Saúde (Santa Maria). 2022, v. 48, n. 1Saúde (Santa Maria); Revista Saúde (Santa Maria). 2022, v. 48, n. 12236-58340103-4499reponame:Saúde (Santa Maria)instname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMporhttps://periodicos.ufsm.br/revistasaude/article/view/67893/47204Copyright (c) 2022 Saúde (Santa Maria)info:eu-repo/semantics/openAccessIncerti, Milena Kerberda Rosa, Taciéli FagundesFoletto, Vitória SegabinazziFranco, Laísa NunesHörner, Rosmari2023-09-08T14:38:26Zoai:ojs.pkp.sfu.ca:article/67893Revistahttps://periodicos.ufsm.br/revistasaudePUBhttps://periodicos.ufsm.br/revistasaude/oairevistasaude.ufsm@gmail.com || amanda.revsaude@gmail.com || beatriz.revsaude@gmail.com2236-58342236-5834opendoar:2023-09-08T14:38:26Saúde (Santa Maria) - Universidade Federal de Santa Maria (UFSM)false |
dc.title.none.fl_str_mv |
Reaproveitamento de medicamentos para COVID-19: uma visão geral |
title |
Reaproveitamento de medicamentos para COVID-19: uma visão geral |
spellingShingle |
Reaproveitamento de medicamentos para COVID-19: uma visão geral Incerti, Milena Kerber Reposicionamento de medicamentos. Redirecionamento de medicamentos. SARS-CoV-2. Coronavírus. |
title_short |
Reaproveitamento de medicamentos para COVID-19: uma visão geral |
title_full |
Reaproveitamento de medicamentos para COVID-19: uma visão geral |
title_fullStr |
Reaproveitamento de medicamentos para COVID-19: uma visão geral |
title_full_unstemmed |
Reaproveitamento de medicamentos para COVID-19: uma visão geral |
title_sort |
Reaproveitamento de medicamentos para COVID-19: uma visão geral |
author |
Incerti, Milena Kerber |
author_facet |
Incerti, Milena Kerber da Rosa, Taciéli Fagundes Foletto, Vitória Segabinazzi Franco, Laísa Nunes Hörner, Rosmari |
author_role |
author |
author2 |
da Rosa, Taciéli Fagundes Foletto, Vitória Segabinazzi Franco, Laísa Nunes Hörner, Rosmari |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Incerti, Milena Kerber da Rosa, Taciéli Fagundes Foletto, Vitória Segabinazzi Franco, Laísa Nunes Hörner, Rosmari |
dc.subject.por.fl_str_mv |
Reposicionamento de medicamentos. Redirecionamento de medicamentos. SARS-CoV-2. Coronavírus. |
topic |
Reposicionamento de medicamentos. Redirecionamento de medicamentos. SARS-CoV-2. Coronavírus. |
description |
The SARS-CoV-2 virus can cause infections in both animals and humans. COVID-19 is an infectious disease caused by this virus and known today for generating great concern worldwide, as it has high rates of transmissibility and pathogenicity and high death rates known worldwide as a result of this infection. For this reason, potential therapeutic strategies are analyzed to contribute to the fight against the COVID-19 pandemic. Some of these therapeutic strategies are carried out through the repositioning of medications. For this opinion study, scientific articles were used, which discussed the repositioning of drugs in COVID-19 and the use of vitamins and minerals in the treatment. It can be seen that the reuse of drugs has several advantages over the implementation of a new drug, such as reduced time to start treatment and reduced financial investment, which leads to a delay in the arrival of purchased drugs and products, especially during this period. pandemic. This drug replacement, with its immediate administration to the patient, ends up causing a delay in the development of the disease course, as well as a lower risk of treatment failure. So far, there is no regularized, standardized and widely publicized therapeutic resource available to the population, however, further studies on this topic should necessarily be encouraged. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-05-23 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.ufsm.br/revistasaude/article/view/67893 10.5902/2236583467893 |
url |
https://periodicos.ufsm.br/revistasaude/article/view/67893 |
identifier_str_mv |
10.5902/2236583467893 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://periodicos.ufsm.br/revistasaude/article/view/67893/47204 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Saúde (Santa Maria) info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Saúde (Santa Maria) |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Santa Maria |
publisher.none.fl_str_mv |
Universidade Federal de Santa Maria |
dc.source.none.fl_str_mv |
Saúde (Santa Maria); Revista Saúde (Santa Maria). 2022, v. 48, n. 1 Saúde (Santa Maria); Revista Saúde (Santa Maria). 2022, v. 48, n. 1 2236-5834 0103-4499 reponame:Saúde (Santa Maria) instname:Universidade Federal de Santa Maria (UFSM) instacron:UFSM |
instname_str |
Universidade Federal de Santa Maria (UFSM) |
instacron_str |
UFSM |
institution |
UFSM |
reponame_str |
Saúde (Santa Maria) |
collection |
Saúde (Santa Maria) |
repository.name.fl_str_mv |
Saúde (Santa Maria) - Universidade Federal de Santa Maria (UFSM) |
repository.mail.fl_str_mv |
revistasaude.ufsm@gmail.com || amanda.revsaude@gmail.com || beatriz.revsaude@gmail.com |
_version_ |
1799944002704769024 |